EPO Patents = 3

Trademarks = 1

Forward Citations = 3

Loading Chart...

13 inventors (with patents filed for the assignee):

John Cameron Bell (2 out of 30 patents)

Nam Hee Lee (2 out of 2 patents)

Caroline Breitbach (2 out of 4 patents)

4. Anne Moon (2 out of 2 patents)

5. Tae-Ho Hwang (2 out of 2 patents)

6. Yu Kyoung Lee (2 out of 2 patents)

7. Mi-kyung Kim (2 out of 2 patents)

8. Tae Ho Hwang (2 out of 3 patents)

9. David H Kirn (2 out of 19 patents)

10. Euna Cho (1 out of 1 patent)

11. Mong Cho (1 out of 1 patent)

12. Ungbae Jeon (1 out of 1 patent)

13. Doo Jin Byun (1 out of 3 patents)

14. Hongjae Jeon (0 patent)

15. Eun Sang Moon (0 patent)

4 patents: Sort by Forward Citations

1. 10646524 - Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof (2020-05-12),

2. 10517910 - Compositions and methods for viral embolization (2019-12-31),

3. 10434169 - Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus (2019-10-08),

4. 9919047 - Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus (2018-03-20),

Sillajen, Inc. is a biotechnology company focused on developing and commercializing oncolytic immunotherapy products for the treatment of cancer. Their lead product candidate, Pexa-Vec, is currently in clinical trials for various types of cancer. Sillajen is dedicated to advancing innovative therapies to improve the lives of patients with cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

4 Patents

#42 in Busan

#2,193 in South Korea

Busan, South Korea

Sillajen, Inc.